| Not Yet Recruiting | Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF HFpEF, LVDD, Myocardial Fibrosis | Phase 2 | 2025-03-18 |
| Recruiting | National Heart Failure Registry Chronic Heart Failure | — | 2024-10-01 |
| Recruiting | ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE Pulmonary Embolism (PE) | N/A | 2024-09-10 |
| Active Not Recruiting | A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Atrial Fibrillation, Atrial Flutter | Phase 2 | 2024-06-03 |
| Active Not Recruiting | Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension | Phase 2 / Phase 3 | 2024-06-01 |
| Recruiting | Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI Myocardial Infarction, Coronary Stenosis, Coronary Microvascular Dysfunction | N/A | 2024-01-29 |
| Recruiting | Russian Registry of Endovascular Closure of PFO Patent Foramen Ovale | — | 2023-12-01 |
| Completed | Assessment of the Impact of Clinical Decision Support Systems Included in Electronic Health Records Chronic Heart Failure (CHF) | — | 2023-10-01 |
| Recruiting | Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI Ischemic Cardiovascular Disease, Multivessel Coronary Artery Disease, Coronary Artery Disease | N/A | 2023-02-17 |
| Active Not Recruiting | Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Heart Failure With Mid Range Ejection Fraction | N/A | 2022-06-01 |
| Completed | Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Cath Atrium; Fibrillation, Atrium; Flutter | N/A | 2022-02-15 |
| Recruiting | Predictors of Poor Prognosis in HFpEF HFpEF | — | 2022-01-31 |
| Completed | Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter Atrial Fibrillation Paroxysmal | Phase 4 | 2022-01-26 |
| Completed | LCZ696 in Advanced LV Hypertrophy and HFpEF Heart Failure, Essential Hypertension | Phase 2 | 2019-05-31 |
| Completed | Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart F Heart Failure, Diastolic, Diabetes Mellitus, Type 2 | Phase 4 | 2019-01-16 |
| Completed | Cardiac Contractility Modulation in Patients With Chronic Heart Failure and the Various Forms of Atrial Fibril Heart Failure, Atrial Fibrillation, Left Ventricular Ejection Fraction | N/A | 2018-08-31 |
| Recruiting | Registry of Arterial Hypertension Arterial Hypertension | — | 2018-06-01 |
| Recruiting | REGistry of Long-term AnTithrombotic TherApy-2 Atrial Fibrillation | — | 2015-01-15 |
| Recruiting | REGistry of Long-term AnTithrombotic TherApy-1 Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease | — | 2015-01-15 |